{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:28:41Z","timestamp":1781216921482,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ophtha.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T07:46:29Z","timestamp":1396424789000},"page":"1501-1507","source":"Crossref","is-referenced-by-count":77,"title":["Systemic Medication and Intraocular Pressure in a British Population"],"prefix":"10.1016","volume":"121","clinical-trial-number":[{"clinical-trial-number":"nct01895972","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anthony P.","family":"Khawaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle P.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Broadway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Garway-Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.Y.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabina","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.02.009_bib1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ophtha.2005.04.018","article-title":"Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study","volume":"112","author":"De Voogd","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.02.009_bib2","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the Early Manifest Glaucoma Trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.02.009_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bjo.51.4.222","article-title":"Propranolol as ocular hypotensive agent","volume":"51","author":"Phillips","year":"1967","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib4","first-page":"179","article-title":"A\u00a0clinical study of effect of oral atenolol on normal intraocular pressure and systemic blood pressure","volume":"37","author":"Chauhan","year":"1989","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0014-4835(75)90126-8","article-title":"Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers","volume":"21","author":"Wettrell","year":"1975","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2014.02.009_bib6","first-page":"e29724","article-title":"Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study","volume":"7","author":"Marcus","year":"2012","journal-title":"PLoS One [serial online]"},{"key":"10.1016\/j.ophtha.2014.02.009_bib7","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The relationship between statin use and open-angle glaucoma","volume":"119","author":"Stein","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.02.009_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2007.03.047","article-title":"Systemic antihypertensive medication and incident open-angle glaucoma","volume":"114","author":"M\u00fcskens","year":"2007","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.ophtha.2014.02.009_bib9","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","article-title":"The EPIC Project: rationale and study design","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib10","article-title":"Cohort profile: a prospective cohort study of objective physical and cognitive capability and visual health in an ageing population of men and women in Norfolk (EPIC-Norfolk 3)","author":"Hayat","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib11","first-page":"1","article-title":"The EPIC-Norfolk Eye Study: rationale, methods and a cross-sectional analysis of visual impairment in a population-based cohort","volume":"3","author":"Khawaja","year":"2013","journal-title":"BMJ Open [serial online]"},{"key":"10.1016\/j.ophtha.2014.02.009_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcrs.2004.10.044","article-title":"Determining in\u00a0vivo biomechanical properties of the cornea with an ocular response analyzer","volume":"31","author":"Luce","year":"2005","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2014.02.009_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/eye.2010.83","article-title":"Evaluation of agreement between intraocular pressure measurements using Goldmann applanation tonometry and Goldmann correlated intraocular pressure by Reichert's ocular response analyser","volume":"24","author":"Ehrlich","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.02.009_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bjo.80.6.532","article-title":"Sublingual timolol\u2013an alternative to topical medication in glaucoma?","volume":"80","author":"Sadiq","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/bjo.59.6.296","article-title":"Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker","volume":"59","author":"Elliot","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02153719","article-title":"A\u00a0dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure","volume":"218","author":"Stenkula","year":"1982","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bjo.67.10.664","article-title":"Comparison of ocular hypotensive effects of 3 dosages of oral atenolol","volume":"67","author":"Tutton","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/jop.1991.7.21","article-title":"A\u00a0prospective study of oral Nadolol in the management of patients with newly diagnosed chronic simple glaucoma","volume":"7","author":"Dowd","year":"1991","journal-title":"J\u00a0Ocul Pharmacol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjo.69.1.38","article-title":"Effect of orally administered nadolol on the intraocular pressure in normal volunteers","volume":"69","author":"Williamson","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib20","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2014.02.009_bib21","unstructured":"Office for National Statistics. Population Estimates for UK,\u00a0England and Wales, Scotland and Northern Ireland, Mid-2012. Available at: http:\/\/www.ons.gov.uk\/ons\/publications\/re-reference-tables.html?edition=tcm:77-319259#tab-all-tables. Released August 8, 2013. Accessed February 4,\u00a02014."},{"key":"10.1016\/j.ophtha.2014.02.009_bib22","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1167\/iovs.09-4821","article-title":"Hypotensive medication, statins, and the risk of glaucoma","volume":"51","author":"Owen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.02.009_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(10)60168-7","article-title":"Management of stable coronary artery disease","volume":"375","author":"Pfisterer","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2014.02.009_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9394(14)75085-8","article-title":"Organic nitrate therapy in glaucoma","volume":"90","author":"Wizemann","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1964.00970010508010","article-title":"Use of nitrate and nitrite vasodilators by glaucomatous patients","volume":"71","author":"Whitworth","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2003.00109.x","article-title":"Aqueous humour flow after a single oral dose of isosorbide-5-mononitrate in healthy volunteers","volume":"81","author":"Kotikoski","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2014.02.009_bib27","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1167\/iovs.11-7853","article-title":"Intraocular pressure and corneal biomechanics in an adult British population: the EPIC-Norfolk eye study","volume":"52","author":"Foster","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.02.009_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/IJG.0b013e3181f7af9b","article-title":"Intraocular pressure and associated factors: the Central India Eye and Medical Study","volume":"20","author":"Jonas","year":"2011","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2014.02.009_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1442-9071.2007.01529.x","article-title":"Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy","volume":"35","author":"De Castro","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ophtha.2009.08.016","article-title":"Simvastatin and disease stabilization in normal tension glaucoma: a cohort study","volume":"117","author":"Leung","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.02.009_bib31","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"B\u00f6sel","year":"2005","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ophtha.2014.02.009_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/exer.1999.0786","article-title":"Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma","volume":"70","author":"Lind\u00e9n","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2014.02.009_bib33","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1167\/iovs.12-9604","article-title":"Antithrombotic medication and incident open-angle glaucoma","volume":"53","author":"Marcus","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.02.009_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-005-0945-2","article-title":"Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients","volume":"61","author":"Nieminen","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0161-6420(00)00081-6","article-title":"Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol","volume":"107","author":"Schuman","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.02.009_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1755-3768.1982.tb05777.x","article-title":"Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockade","volume":"60","author":"Mar\u00e9n","year":"1982","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2014.02.009_bib37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1442-9071.2007.01573.x","article-title":"Co-prescribing of topical and systemic beta-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice","volume":"35","author":"Goldberg","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib38","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1167\/iovs.09-4867","article-title":"Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: the Singapore Malay Eye Study","volume":"51","author":"Zheng","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.02.009_bib39","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1167\/iovs.08-2956","article-title":"Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study","volume":"51","author":"Memarzadeh","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.02.009_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"issue":"suppl 3","key":"10.1016\/j.ophtha.2014.02.009_bib41","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00005344-199117003-00006","article-title":"The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions","volume":"17","author":"Feelisch","year":"1991","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0039-6257(97)84043-X","article-title":"Nitric oxide in the eye: multifaceted roles and diverse outcomes","volume":"42","author":"Becquet","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1076\/ceyr.26.2.119.14511","article-title":"Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits","volume":"26","author":"Kotikoski","year":"2003","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.ophtha.2014.02.009_bib44","first-page":"BR1","article-title":"Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure","volume":"9","author":"Kotikoski","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ophtha.2014.02.009_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/108076802317233171","article-title":"Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP","volume":"18","author":"Kotikoski","year":"2002","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2014.02.009_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00171028","article-title":"The effect of isosorbide-mononitrate eye drops on the human intraocular pressure and aqueous humor dynamics","volume":"15","author":"Diestelhorst","year":"1991","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.02.009_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14756366.2011.597749","article-title":"A\u00a0new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology","volume":"27","author":"Fabrizi","year":"2012","journal-title":"J\u00a0Enzyme Inhib Med Chem"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T01:55:03Z","timestamp":1538704503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0161642014001390"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.02.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}